Search
for
Sort by
Research 571–600 of 876
- DERMATOLOGICAL AND SYSTEMIC REACTIONS TO HAIR DYES: CURRENT EVIDENCE AND MANAGEMENT
- Lipid nanocarriers as innovative strategies for hair regrowth
- The Role of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo: A Review article
- Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies
- Case Report: Vitiligo and Alopecia Universalis Following Rituximab Therapy in a Patient with Myasthenia Gravis
- Managing androgenic alopecia with individualised homeopathic medicine and biochemic remedies- An evidence based single case report
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- Long-Term Multimodal Reconstruction of Extensive Post-Burn Scalp Alopecia Using Tissue Expansion and Follicular Unit Extraction: A 10-Year Follow-Up Case Report
- Familial Pure Hair–Nail Ectodermal Dysplasia in Yemen: A Father–Son Case Report with Clinical Correlation
- A decade of progress in androgenetic alopecia management: Emerging therapies and multimodal strategies
- Hair for the Long Haul: Alopecia Areata Cases and Considerations
- Efficacy, Safety, and Tolerability of Upadacitinib in Adults and Adolescents With Severe Alopecia Areata: Results From the Randomized, Placebo-Controlled, Double-Blind Phase 3 Program (UP-AA)
- Baricitinib Provides Significant Hair Regrowth In Adolescents With Severe Alopecia Areata: 52-Week Efficacy and Safety Results From A Phase 3 Randomized, Controlled Trial
- Baricitinib Provides Higher Efficacy in Adolescents Relative to Adults With Alopecia Areata Despite More Severe Disease at Baseline: 36-Week Outcomes From BRAVE-AA Trials
- Comparative Evaluation of Oral Baricitinib and Tofacitinib in Alopecia Areata: A Retrospective Cohort Study Based on SALT Scores
- Case Series and Literature Review on Tofacitinib for Treating Severe Alopecia Areata
- Rationale and Design of a Novel, Phase 3, External and Synthetic Placebo-Controlled Clinical Trial of Ritlecitinib 50 mg and 100 mg for Alopecia Areata
- Baricitinib in the Management of Severe Alopecia Areata: A Report of Two Cases With Sustained Clinical Response
- Scalp hair cortisol concentration in patients with alopecia areata and correlate its level with the disease variables
- Patient Validation of Estimation of Health Utility Values in Alopecia Areata
- Prediction of Long-term Scalp Hair Regrowth at 24 Months in Patients with Alopecia Areata Receiving Ritlecitinib Treatment in the ALLEGRO Clinical Trial Program
- Treatment of frontal fibrosing alopecia: literature review 2020-2025
- Medical Physics in Aesthetic Medicine: Innovations and Techniques for Cosmetic Procedures in 2025
- Hair Product Allergy: A Review of Epidemiology and Management
- Achieving Natural Aesthetics in Brow Hair Transplantation: Challenges and Solutions
- Alopecia areata
- Developing the Concept of ‘Feel Ezzy Hair Oil’: Explore the Nature of Hair Oil with Respect to Personal Well-Being
- Androgenetic Alopecia: Therapy Update
- FFA and Personal Care Product Use: A Systematic Review and Meta-Analysis
- Present Chemotherapy Induced Alopecia and Research in Future